Brian K. Meyer
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery 2
- Cancer Research top 10%
-
- Protein purification and stability 3
- Heat shock proteins research 2
-
- Biosimilars and Bioanalytical Methods 2
-
- Herpesvirus Infections and Treatments 2
- Hepatitis B Virus Studies 2
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- SARS-CoV-2 and COVID-19 Research 1
Brian K. Meyer
13 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Health, Toxicology and Mutagenesis 258
- Pharmaceutical Science 85
- Cancer Research 184
- Molecular Biology 642
- Immunology 189
Countries citing papers authored by Brian K. Meyer
This map shows the geographic impact of Brian K. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian K. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian K. Meyer more than expected).
Fields of papers citing papers by Brian K. Meyer
This network shows the impact of papers produced by Brian K. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian K. Meyer. The network helps show where Brian K. Meyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian K. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2020 | 21 | |
| 3 | 2019 | 23 | |
| 4 | 2016 | 32 | |
| 5 | 2012 | 12 | |
| 6 | 2011 | 35 | |
| 7 | 2010 | 35 | |
| 8 | 2010 | 263 | |
| 9 | 2007 | 131 | |
| 10 | Impact of tubing material on the failure of product-specific bubble points of sterilizing-grade filters. | 2006 | 2 |
| 11 | 2000 | 78 | |
| 12 | 1999 | 182 | |
| 13 | 1998 | 313 |
About Brian K. Meyer
Brian K. Meyer is a scholar working on Pharmaceutical Science, Microbiology, Immunology, Clinical Biochemistry and Epidemiology, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protein purification and stability (3 papers), Advancements in Transdermal Drug Delivery (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Herpesvirus Infections and Treatments (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Hepatitis B Virus Studies (2 papers), Heat shock proteins research (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Health, Toxicology and Mutagenesis (258 citations), Pharmaceutical Science (85 citations), Cancer Research (184 citations), Molecular Biology (642 citations) and Immunology (189 citations). Brian K. Meyer has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Gary H. Perdew, Marilyn G. Pray-Grant, John P. Vanden Heuvel, Li Shi, John R. Petrulis, Jeffrey T. Blue, Michel Awwad, Linda O. Narhi, Hanns‐Christian Mahler and Nataliya Afonina. Their work appears in journals such as Journal of Pharmaceutical Sciences, Vaccine X, AAPS PharmSciTech, Journal of Pharmaceutical Innovation and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.